相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
R. Bouamar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Lessons From Routine Dose Adjustment of Tacrolimus in Renal Transplant Patients Based on Global Exposure
Franck Saint-Marcoux et al.
THERAPEUTIC DRUG MONITORING (2013)
Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum
Mary F. Hebert et al.
TRANSPLANTATION (2013)
Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs
P. A. Jacobson et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Calculation of Normalized Drug Concentrations in the Presence of Altered Plasma Protein Binding
Florin Marcel Musteata
CLINICAL PHARMACOKINETICS (2012)
In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
H. de Jonge et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation
P. Stratta et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation
Flora Tshinanu Musuamba et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Anemia and Erythrocytosis in patients after kidney transplantation
Jolanta Malyszko et al.
TRANSPLANT INTERNATIONAL (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients
Katherine A. Barraclough et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Dosing equation for tacrolimus using genetic variants and clinical factors
Chaitali Passey et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf® and once daily Advagraf®
Jean-Baptiste Woillard et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
Karsten Midtvedt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Evaluation of a New Immunoassay for Therapeutic Drug Monitoring of Tacrolimus in Adult Liver Transplant Recipients
Shigeru Marubashi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
Khaled Benkali et al.
CLINICAL PHARMACOKINETICS (2009)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference
Pierre Wallemacq et al.
THERAPEUTIC DRUG MONITORING (2009)
Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients
Rogier R. Press et al.
THERAPEUTIC DRUG MONITORING (2009)
Rimonabant Affects Cyclosporine A, but Not Tacrolimus Pharmacokinetics in Renal Transplant Recipients
Rune Amundsen et al.
TRANSPLANTATION (2009)
The Challenge of Achieving Target Drug Concentrations in Clinical Trials: Experience From the Symphony Study
Henrik Ekberg et al.
TRANSPLANTATION (2009)
Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay
Takashi Tomita et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Reduced Elimination of Cyclosporine A in Elderly (>65 Years) Kidney Transplant Recipients
Pal Falck et al.
TRANSPLANTATION (2008)
Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients
Pal Falck et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Therapeutic monitoring of calcineurin inhibitors for the nephrologist
Jeffrey Schiff et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Influence of different allelic variants of the CYP3A and ABCB1 genes on the tacrolimus pharmacokinetic profile of Chinese renal transplant recipients
Chi Yuen Cheung et al.
PHARMACOGENOMICS (2006)
AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients
EM Scholten et al.
KIDNEY INTERNATIONAL (2005)
High initial blood levels of tacrolimus in overweight renal transplant recipients
E Rodrigo et al.
TRANSPLANTATION PROCEEDINGS (2005)
Quantification of lean bodyweight
S Janmahasatian et al.
CLINICAL PHARMACOKINETICS (2005)
The influence of age and sex on the clearance of cytochrome P450 3A substrates
MM Cotreau et al.
CLINICAL PHARMACOKINETICS (2005)
Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids - A prospective study in one hundred de novo renal transplant recipients
DRJ Kuypers et al.
CLINICAL PHARMACOKINETICS (2004)
Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability
T Kerbusch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
分享论文
